Leiden University Medical Center (LUMC) has opened a dedicated department for CAR-T cell therapy, bringing care, research and expertise in this rapidly developing field together in one place. The new department, officially opened on 24 September, marks another step in…
Leiden-based biotech company VarmX has received two industry award nominations recognising its scientific approach and strategic partnership with CSL. VarmX has been shortlisted for the 2026 Prix Galien USA “Best Startup” Award, which recognises early-stage companies developing novel therapeutic approaches.…
The municipality of Katwijk has approved the permit application for a new pharmaceutical manufacturing facility by US-based Eli Lilly. The planned €3 billion investment will create around 500 jobs and further strengthen the life sciences and health ecosystem in the…
On 24 September, Leiden Bio Science Park welcomed participants of BioCentury Grand Rounds Europe for an ecosystem tour in Leiden. The international delegation included biotech founders, investors, biopharma executives and other life sciences leaders taking part in the 2026 edition…
On 24 September, Leiden Bio Science Park welcomed participants of BioCentury Grand Rounds Europe for an ecosystem tour in Leiden. The international delegation included biotech founders, investors, biopharma executives and other leaders from across the life sciences sector. The programme…
Leiden Bio Science Park welcomed Minister Heleen Herbert of Economic Affairs and Director-General Erwin Nijsse for a visit focused on the future of red biotech in the Netherlands. The programme brought together government, industry, science and the region to discuss…
Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced positive results from a Phase 1 study of RIG-101, an investigational intranasal innate immune modulator being developed to prevent the consequences of common respiratory viral infections in vulnerable patients. Results…
VitroScan is celebrating its 10-year anniversary. The Leiden-based company has spent the past decade developing ex vivo micro-tumour testing, with the aim of supporting better-informed treatment decisions for cancer patients. Founded in 2016, VitroScan has grown its technology and network…
A new place for coffee, breakfast, lunch and drinks is coming to Leiden Bio Science Park. On 1September, Vascobelo V-Bar Leiden Bio Science Park will officially open its doors at Einsteinweg4D, in the new MORE development area. Located opposite Leiden…
BioMarin Pharmaceutical Inc. (BioMarin) has agreed to acquire Alesta Therapeutics for $275 million upfront and up to $215 million in development and regulatory milestones, for a total of up to $490 million. The transaction has been approved by both companies’…
MIMETAS’ unique organ-on-a-chip and human tissue models complement Bruker’s multiomics, NMR, spatial biology and preclinical imaging solutions LEIDEN, The Netherlands–(BUSINESS WIRE)–Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue…
Immunotherapy turns the body’s own immune system against cancer. It can be strikingly effective, but it has limits, and a LUMC team wants to push past them by combining two approaches that each engage the immune system in a different…